Abstract
Scientists and technicians have been innovative to develop experimental platforms in order to achieve functional weightless conditions in their Earth-bound laboratories. As a result, various experimental platforms are available in order to perform studies with molecules or single cells up to humans and to study gravity-related mechanisms.
These ground-based simulators of microgravity are not only tools to prepare spaceflight experiments, but they have been established as stand-alone facilities for gravitational research.
This review provides an overview of some of the most frequently used microgravity simulators, most of which are in use at DLR´s Institute of Aerospace Medicine at Cologne, Germany. Their individual capacities but also experimental limitations, especially regarding their range of applicability for biological specimens, are exemplarily reviewed here. Overall, it is necessary to compare data achieved by using simulators with the data obtained in real microgravity. Furthermore, it should be carefully considered which kind of simulation might be the optimum for a given model organism or cell.
Keywords: Space biology, gravitational biology, gravity, microgravity, clinostat, random positioning machine.
Current Biotechnology
Title:Simulation of Microgravity for Studies in Gravitational Biology: Principles, Devices and Applications
Volume: 2 Issue: 3
Author(s): Ralf Anken
Affiliation:
Keywords: Space biology, gravitational biology, gravity, microgravity, clinostat, random positioning machine.
Abstract: Scientists and technicians have been innovative to develop experimental platforms in order to achieve functional weightless conditions in their Earth-bound laboratories. As a result, various experimental platforms are available in order to perform studies with molecules or single cells up to humans and to study gravity-related mechanisms.
These ground-based simulators of microgravity are not only tools to prepare spaceflight experiments, but they have been established as stand-alone facilities for gravitational research.
This review provides an overview of some of the most frequently used microgravity simulators, most of which are in use at DLR´s Institute of Aerospace Medicine at Cologne, Germany. Their individual capacities but also experimental limitations, especially regarding their range of applicability for biological specimens, are exemplarily reviewed here. Overall, it is necessary to compare data achieved by using simulators with the data obtained in real microgravity. Furthermore, it should be carefully considered which kind of simulation might be the optimum for a given model organism or cell.
Export Options
About this article
Cite this article as:
Anken Ralf, Simulation of Microgravity for Studies in Gravitational Biology: Principles, Devices and Applications, Current Biotechnology 2013; 2 (3) . https://dx.doi.org/10.2174/22115501113029990012
DOI https://dx.doi.org/10.2174/22115501113029990012 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Glutamine, Glucose and other Fuels for Cancer
Current Pharmaceutical Design Growth Hormone Secretagogue (Ghrelin-) Receptors - A Complex Drug Target for the Regulation of Body Weight
CNS & Neurological Disorders - Drug Targets High CXCR4 Expression Correlates with Sunitinib Poor Response in Metastatic Renal Cancer
Current Cancer Drug Targets The Use of Technetium-99m Radiolabeled Human Antimicrobial Peptides for Infection Specific Imaging
Mini-Reviews in Medicinal Chemistry Bioinformatic Tools Identify Chromosome-Specific DNA Probes and Facilitate Risk Assessment by Detecting Aneusomies in Extra-embryonic Tissues
Current Genomics De Novo DNMTs and DNA Methylation: Novel Insights into Disease Pathogenesis and Therapy from Epigenomics
Current Pharmaceutical Design Prognostic Implications of microRNA-155, -133a, -21 and -205 in Breast Cancer Patients’ Plasma
MicroRNA Sulforaphane Treatment of Young Men with Autism Spectrum Disorder
CNS & Neurological Disorders - Drug Targets The Identification of Three Key Genes Related to Stemness in Thyroid Carcinoma through Comprehensive Analysis
Combinatorial Chemistry & High Throughput Screening Takotsubo Cardiomyopathy
Current Pharmaceutical Design Role of Hexokinase and VDAC in Neurological Disorders
Current Molecular Pharmacology Breast Cancer: Understanding Sensitivity and Resistance to Chemotherapy and Targeted Therapies to Aid in Personalised Medicine
Current Cancer Drug Targets Lipid-based Nano-phytomedicines for Disease Treatment and Theranostic Applications
Current Nanomedicine Biological Drugs in Guillain-Barré Syndrome: An Update
Current Neuropharmacology Clinical PET Imaging of Insulinoma and Beta-Cell Hyperplasia
Current Pharmaceutical Design Preventive and Therapeutic Effects of the Retinoid X Receptor Agonist Bexarotene on Tumors
Current Drug Metabolism Blockade of Neoangiogenesis, a New and Promising Technique to Control the Growth of Malignant Tumors and their Metastases
Current Vascular Pharmacology Tumor Markers in Patients with Benign and Malignant Pulmonary Diseases; Competitive Evaluation of ProGRP, NSE and Cyfra 21-1
Recent Patents on Biomarkers Structure, Function and Polymorphism of Human Cytosolic Sulfotransferases
Current Drug Metabolism The Role of Androgen Receptor Mutations in Prostate Cancer Progression
Current Genomics